Vanguard Personalized Indexing Management LLC Grows Stock Holdings in Cardinal Health, Inc. $CAH

Vanguard Personalized Indexing Management LLC raised its position in shares of Cardinal Health, Inc. (NYSE:CAH) by 22.6% during the second quarter, HoldingsChannel reports. The firm owned 44,028 shares of the company’s stock after purchasing an additional 8,127 shares during the period. Vanguard Personalized Indexing Management LLC’s holdings in Cardinal Health were worth $7,397,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in the company. Concurrent Investment Advisors LLC raised its position in Cardinal Health by 5.7% during the second quarter. Concurrent Investment Advisors LLC now owns 8,890 shares of the company’s stock valued at $1,494,000 after purchasing an additional 483 shares in the last quarter. Aberdeen Group plc raised its position in Cardinal Health by 14.2% during the second quarter. Aberdeen Group plc now owns 229,460 shares of the company’s stock valued at $38,549,000 after purchasing an additional 28,520 shares in the last quarter. Strengthening Families & Communities LLC raised its position in Cardinal Health by 6,124.8% during the second quarter. Strengthening Families & Communities LLC now owns 9,275 shares of the company’s stock valued at $1,558,000 after purchasing an additional 9,126 shares in the last quarter. PDS Planning Inc raised its position in Cardinal Health by 3.7% during the second quarter. PDS Planning Inc now owns 7,139 shares of the company’s stock valued at $1,199,000 after purchasing an additional 257 shares in the last quarter. Finally, Monument Capital Management raised its position in Cardinal Health by 356.0% during the second quarter. Monument Capital Management now owns 19,793 shares of the company’s stock valued at $3,325,000 after purchasing an additional 15,452 shares in the last quarter. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Cardinal Health Trading Down 0.2%

Cardinal Health stock opened at $156.86 on Monday. The firm has a 50-day moving average of $152.09 and a 200-day moving average of $151.31. The firm has a market cap of $37.27 billion, a P/E ratio of 24.32, a P/E/G ratio of 1.33 and a beta of 0.71. Cardinal Health, Inc. has a 1-year low of $106.98 and a 1-year high of $168.44.

Cardinal Health (NYSE:CAH) last posted its earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share for the quarter, topping analysts’ consensus estimates of $2.03 by $0.05. The company had revenue of $60.16 billion during the quarter, compared to analyst estimates of $60.91 billion. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. Cardinal Health’s revenue for the quarter was up .5% on a year-over-year basis. During the same period in the prior year, the business posted $1.84 earnings per share. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. Research analysts forecast that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st will be issued a dividend of $0.5107 per share. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.3%. The ex-dividend date is Wednesday, October 1st. Cardinal Health’s dividend payout ratio is currently 31.63%.

Insider Activity at Cardinal Health

In other news, insider Ola M. Snow sold 28,151 shares of the stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $148.94, for a total transaction of $4,192,809.94. Following the completion of the sale, the insider directly owned 15,431 shares in the company, valued at approximately $2,298,293.14. This represents a 64.59% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Michelle D. Greene sold 13,500 shares of the stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total transaction of $2,009,070.00. Following the sale, the insider owned 14,976 shares of the company’s stock, valued at approximately $2,228,728.32. This represents a 47.41% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 271,676 shares of company stock valued at $40,489,525 in the last quarter. 0.12% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on CAH. Leerink Partners raised their price target on Cardinal Health from $186.00 to $187.00 and gave the company an “outperform” rating in a research report on Monday, October 6th. Weiss Ratings reaffirmed a “buy (b)” rating on shares of Cardinal Health in a research note on Wednesday, October 8th. Argus set a $189.00 price objective on Cardinal Health in a research note on Friday, August 22nd. Jefferies Financial Group set a $150.00 price objective on Cardinal Health in a research note on Tuesday, August 12th. Finally, Wall Street Zen cut Cardinal Health from a “strong-buy” rating to a “buy” rating in a research note on Saturday, August 2nd. Twelve analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $166.00.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.